Optocred Pharmaceuticals launches eye-care products to combat digital eye strain

Amid the Covid-19 pandemic, increased digital screen time among country residents, particularly children, and teenagers enrolled in online education has increased the country's burden of rising digital eye strain or computer vision syndrome. Optocred Pharmaceuticals has earned many firsts in the Ophthalmic industry in India For the first time in the Ophthalmic industry in India, Optocred Pharmaceuticals has brought in a range of eye-care products, which are of very high quality and cost-effective to provide eye care solutions amid the Covid-19 pandemic. Led by highly experienced quality assurance, production and R&D teams, Optocred Pharmaceuticals incorporated in 2022, has earned many firsts in the Ophthalmic industry in India with the core purpose of helping the patients with its continued innovation and research. Raw ingredients, packaging materials, consumables, and other inputs must all pass severe quality checks, and only high-quality components are utilised in the formulations The company has been conducting frequent surveys, soliciting comments from a variety of healthcare professionals, and sharing crucial data with companies developing emerging technologies to improve research and development to offer solutions for eye problems.